Publication: Infective endocarditis on transcatheter aortic prosthesis: Are there differences with endocarditis on surgically implanted aortic bioprosthesis?
Loading...
Identifiers
Date
2021-10-28
Authors
Fernandez-Aviles, Consuelo
Castillo, Juan C
Heredia, Gloria
Resua, Adriana
Gonzalez, Rafael
Pan, Manuel
Anguita, Manuel
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Wydawnictwo Via Medica
Abstract
Transcatheter aortic valve implantation (TAVI) has been a major advance in the treatment of aortic stenosis in elderly patients or those at very high
surgical risk, and its indication has been extended to cases of high or even intermediate risk. For this reason, its use has increased notably in the
past years [1]. One of the problems associated with TAVI is bioprosthesis infection [2]. The development of infective endocarditis (IE) on TAVI
(IETAVI) is a serious complication, with the added problem that in many cases open-heart surgery is necessary to manage it.
Description
MeSH Terms
Aortic valve
Bioprosthesis
Humans
Prosthesis design
Prosthesis failure
Bioprosthesis
Humans
Prosthesis design
Prosthesis failure
DeCS Terms
Bioprótesis
Diseño de prótesis
Falla de prótesis
Válvula aórtica
Diseño de prótesis
Falla de prótesis
Válvula aórtica
CIE Terms
Keywords
Endocarditis, Endocarditis, bacterial, Heart valve prosthesis, Heart valve prosthesis implantation
Citation
Fernández-Avilés C, Castillo JC, Heredia G, Resúa A, González R, Pan M, et al. Infective endocarditis on transcatheter aortic prosthesis: Are there differences with endocarditis on surgically implanted aortic bioprosthesis? Cardiol J. 2022;29(3):511-513